Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
PremjiInvest
AddedFeb 13, 2024
UpdatedJun 28, 2026
PremjiInvest

PremjiInvest

Operating

PremjiInvest: A venture capital firm in India, targeting early and late-stage investments in textiles, healthcare, and hospitality.

Location
Delhi, Delhi, IN
Founded
2006
Firm
Compare
Portfolio
Employees
News
Website

Investments

Upscale AI
Upscale AI
Series A

Total Raised

$490M

Rounds

3

Series A$190MJune 2026
Series A$200MJanuary 2026
Runway
Runway
Series E

Total Raised

$551.5M

Rounds

7

Series E$315MFebruary 2026
Bicara Therapeutics
Bicara Therapeutics

Total Raised

$313M

Rounds

3

Series C$165MDecember 2023
Series B$108MMarch 2023
Ikigai
Ikigai

Total Raised

$38.2M

Rounds

3

Series A$25MAugust 2023
Navan
Navan

Total Raised

$2.2B

Rounds

15

Series G$154MOctober 2022
LambdaTest
LambdaTest

Total Raised

$70M

Rounds

6

Series C$45MMarch 2022
Pixis
Pixis

Total Raised

$209M

Rounds

5

Series C$100MJanuary 2022
Series B$17MSeptember 2021
Sysdig
Sysdig

Total Raised

$729.5M

Rounds

9

Series G$350MDecember 2021
Series F$188MApril 2021
Heyday
Heyday

Total Raised

$806.5M

Rounds

6

Series C$555MNovember 2021
Devoted Health
Devoted Health

Total Raised

$2.1B

Rounds

6

Series D$1.1BOctober 2021
Series C$450MApril 2020
Elemy
Elemy

Total Raised

$323M

Rounds

3

Series B$219MOctober 2021
Amagi
Amagi

Total Raised

$349.7M

Rounds

8

Series Unknown$100MSeptember 2021
SonderMind
SonderMind

Total Raised

$183M

Rounds

6

Series C$150MJuly 2021
Outreach
Outreach

Total Raised

$489M

Rounds

13

Series G$200MJune 2021
Cohesity
Cohesity

Total Raised

$805M

Rounds

6

Secondary Market$145MMarch 2021
Icertis
Icertis

Total Raised

$516M

Rounds

11

Series F$80MMarch 2021
Series E$115MJuly 2019
Innovium
Innovium
Acquired

Total Raised

$402.3M

Rounds

11

Series F$170MJuly 2020
Mapbox
Mapbox

Total Raised

$614.2M

Rounds

8

Series D$107MMay 2020
Iora Health
Iora Health
Acquired

Total Raised

$349.3M

Rounds

7

Series F$126MFebruary 2020